InsiderTrades

Form 4 for LH Labcorp

Accepted 2026-08-05 11:17:41 ET · period of report 2026-08-03 · accession 0000920148-26-000172 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-08-05 11:17 2026-08-03 LH Wilkinson Peter J SVP, CAO S - Sale+OE $309.23 -1,420 1,770 -45% -$439.1K
D 2026-08-05 11:17 2026-08-03 LH Wilkinson Peter J SVP, CAO M - OptEx $209.25 +1,338 3,108 +76% +$280.0K
D 2026-08-05 11:17 2026-08-03 LH Wilkinson Peter J SVP, CAO M - OptEx $0.00 -1,338 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-03 S D 82 $309.22 1,770.22 D — —
2 Common Common Stock 2026-08-03 M A 1,338 $209.25 3,108.22 D — —
3 Common Common Stock 2026-08-03 S D 1,338 $309.23 1,770.22 D — —
4 Derivative Non-qualified Stock Options 2026-08-03 M D 1,338 $0.00 0 D $209.25 · 2022-02-02 to 2031-02-01 1,338 Common Stock (F1) Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. (F2) Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea. (F3) The options vested in three equal annual installments beginning on the date reflected in this column and are now fully exercisable.